An off-stage conversation with Emre Özcan, SVP, Global Head of Digital Health and Devices at Merck Group, following the fireside chat he joined with Alessandro de Luca, Head of Digital Enterprise Solutions at Merck, and Roberto Ascione, Frontiers Health Chairman and President, Health Innovation at EVERSANA.

They discussed how the convergence of science and technology is redefining the future of pharma. The conversation explored how digital innovation is reshaping clinical development, commercial models, and patient engagement. It examined the opportunities and challenges in integrating evidence-based digital interventions alongside pharmacological therapies, setting the foundation for the next generation of hybrid, personalized care.